Management of atrial fibrillation

摘要

Gregory Lip and Hung-FatTse (Aug 18, p 604) examine the delicate issue of thromboprophylaxis in patients with atrial fibrillation after percutaneous coronary interventions. However, they do not weigh the benefits of coronary stenting, on one hand, with the potential complications of combined therapy with aspirin, clopidogrel, and warfarin, as well as the consequences ofstent thrombosis, on the other.In stable coronary artery disease, the key issue is not how to treat patients with atrial fibrillation after coronary stenting, but whether such patients should be sent to the cath lab in the first place. In fact, medical therapy and myocardial revascularisation, in this particular context, are associated with similar prognoses